Low Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: a Study in an Indian Population

Srini Satya Vasan, Reddy Kumar Rahul, Shultz Tamar, Denes Bela:
The Canadian Journal of Urology, Feb 2015 (Volume 22, Issue 1, Pages 7614 – 7622)
Erectile dysfunction (ED) has been shown to be associated with a number of physical conditions and affects not only physical but also psychosocial health. Currently oral, on-demand phosphodiesterase type 5 inhibitors (PDE5i) are preferred first line treatment. Though effective, these drugs have limitations and are associated with significant non-compliance, side effects and do not reverse the underlying pathology. Non-invasive low intensity shockwave therapy (LISWT) has been shown to significantly improve erectile function in men previously PDE5i dependent. We describe our experience and results with this therapy in an Indian population of men with ED. This study assessed the efficacy of low intensity extracorporeal shockwave therapy (LI-ESWT) on Indian men with organic ED who had previously responded to PDE5i